AFT Pharmaceuticals

Started by Hectorplains, Jan 09, 2023, 09:22 AM

Previous topic - Next topic

0 Members and 1 Guest are viewing this topic.

Rawz

AFT SP looks to have moved into an uptrend (based on limited TA knowledge). This combined with what I am expecting to be positive fundamental news flow off the back of their $300m revenue target should help the SP grind higher and higher.

Disc. hold.

BlackPeter

Quote from: Rawz on Today at 10:50 AMAFT SP looks to have moved into an uptrend (based on limited TA knowledge). This combined with what I am expecting to be positive fundamental news flow off the back of their $300m revenue target should help the SP grind higher and higher.

Disc. hold.

Hmm - yes, SP managed to get over MA50 and MA200 - and even went through MA400.

Could be a trend change or could be just onother of these blibs the SP had throughout the big downtrend since 2020.

I stopped a long time ago to follow them ... did they change their strategy to spread potentially good sounding data without revenue impact? You mention a revenue goal. More interesting would be - do they make money at a reasonable PE and is earnings growth visible? Their only economically interesting tablet used to be to put Aspirin plus Ibuprufen into one tablet. Obviously - every doctor and most other people know about that and get the same benefit by just prescribing / buying cheap aspirin plus cheap Ibuprofen instead of buying an expensive Maxigesic.   

Do they have anything which customers can't get much cheaper in the boxes next to theirs ...

Basil

Last 5 years eps have been 7,19,10,15 and 11cps according to invest directs website, (that track record of eps does not inspire me at all in the context of a FY25 PE of 26 times earnings).  Sales growth is one thing, eps growth is quite another.

Just as well the future is going to be so much different with average broker forecasts of 16, 20 and 25 cps in the next 3 years https://www.marketscreener.com/quote/stock/AFT-PHARMACEUTICALS-LIMIT-27329668/finances/

I wrote a detailed post recently wherein I stated my belief that 80-90% weight should be put on what a company has actually achieved in the last 5 years and 10-20% on what they say they're going to do in the future.    Brokers think its worth $3.80.    Best wishes to shareholders.  Its not for me.

FatTed

 

Do they have anything which customers can't get much cheaper in the boxes next to theirs ...
[/quote]

Many Hospital medications, although I cant find a list of them